Regadenoson

• Prognostic Performance of Quantitative Myocardial Perfusion Imaging Using H2[15O] Positron Emission Tomography in Coronary Artery Disease - … Pending
  2024-518706-41-01 Phase III 1 country Vaestra Goetalandsregionen
• Evaluation of patients with total coronary occlusions with multimodality image. Pending
  2024-519979-26-00 Phase IV 1 country Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques Augus…
• Colchicine for ischemia with no obstructive coronary artery disease and microvascular dysfunction Recruiting
  2023-507981-17-00 Phase II 1 country Region Hovedstaden
• A clinical trial to be conducted in many hospitals and in different countries with the medicinal substance Regadenoson to be used in a type … Recruiting
  2024-515244-22-00 Phase I/II 3 countries GE Healthcare Limited
• Absolute quantification of myocardial blood flow in human subjects with SYN2 dynamic PET imaging Recruiting
  2023-507520-23-00 Phase II 1 country Synektik S.A.
• A Phase III Prospective, Multicenter, Open-label Study to Assess Diagnostic Efficacy of a Novel 18F-labelled Tracer, SYN2, for Positron Emis… Recruiting
  2023-506971-89-00 Phase III 5 countries Synektik S.A.
• A study to evaluate the safety and effectiveness of a new gene therapy (XC001) for people with coronary artery disease and reduced heart fun… Ended
  2025-521325-33-00 Phase II 4 countries Xylocor Therapeutics Inc.

Showing 1–7 of 7 trials